191 related articles for article (PubMed ID: 38087395)
1. Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementia.
Chua XY; Torta F; Chong JR; Venketasubramanian N; Hilal S; Wenk MR; Chen CP; Arumugam TV; Herr DR; Lai MKP
Alzheimers Res Ther; 2023 Dec; 15(1):214. PubMed ID: 38087395
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.
Chua XY; Chai YL; Chew WS; Chong JR; Ang HL; Xiang P; Camara K; Howell AR; Torta F; Wenk MR; Hilal S; Venketasubramanian N; Chen CP; Herr DR; Lai MKP
Alzheimers Res Ther; 2020 Sep; 12(1):122. PubMed ID: 32998767
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of
den Hoedt S; Dorst-Lagerwerf KY; de Vries HE; Rozemuller AJM; Scheltens P; Walter J; Sijbrands EJG; Martinez-Martinez P; Verhoeven AJM; Teunissen CE; Mulder MT
J Alzheimers Dis Rep; 2023; 7(1):339-354. PubMed ID: 37220621
[TBL] [Abstract][Full Text] [Related]
4. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence.
Chew WS; Torta F; Ji S; Choi H; Begum H; Sim X; Khoo CM; Khoo EYH; Ong WY; Van Dam RM; Wenk MR; Tai ES; Herr DR
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162145
[TBL] [Abstract][Full Text] [Related]
5. Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B.
Ren Y; Zhao J; Xu M; Wang Y; Bai L; Jiang Y; Liu S; Chen Y; Duan Z; Zheng S
Int J Med Sci; 2022; 19(14):2080-2086. PubMed ID: 36483591
[No Abstract] [Full Text] [Related]
6. Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease.
You Q; Peng Q; Yu Z; Jin H; Zhang J; Sun W; Huang Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830858
[TBL] [Abstract][Full Text] [Related]
7. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
[TBL] [Abstract][Full Text] [Related]
8. Targeted lipidomics reveals associations between serum sphingolipids and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp.
Ye J; Ye X; Jiang W; Lu C; Geng X; Zhao C; Ma Y; Yang P; Man Lam S; Shui G; Yang T; Zhong Li J; Gong Y; Fu Z; Zhou H
Diabetes Res Clin Pract; 2021 Mar; 173():108699. PubMed ID: 33592213
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
10. The sphingolipids change in exosomes from cancer patients and association between exosome release and sphingolipids level based on a pseudotargeted lipidomics method.
Yang K; Fu W; Deng M; Li X; Wu M; Wang Y
Anal Chim Acta; 2024 May; 1305():342527. PubMed ID: 38677835
[TBL] [Abstract][Full Text] [Related]
11. Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
Shammout ODA; Ashmawy NS; Shakartalla SB; Altaie AM; Semreen MH; Omar HA; Soliman SSM
PLoS One; 2021; 16(10):e0258363. PubMed ID: 34637456
[TBL] [Abstract][Full Text] [Related]
12. Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C.
Li JF; Qu F; Zheng SJ; Ren F; Wu HL; Liu M; Ren JY; Chen Y; Duan ZP; Zhang JL
Mol Med Rep; 2015 Jul; 12(1):323-30. PubMed ID: 25695872
[TBL] [Abstract][Full Text] [Related]
13. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
Han X; Rozen S; Boyle SH; Hellegers C; Cheng H; Burke JR; Welsh-Bohmer KA; Doraiswamy PM; Kaddurah-Daouk R
PLoS One; 2011; 6(7):e21643. PubMed ID: 21779331
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-β42, tau, and phospho-tau-181 levels.
Koal T; Klavins K; Seppi D; Kemmler G; Humpel C
J Alzheimers Dis; 2015; 44(4):1193-201. PubMed ID: 25408209
[TBL] [Abstract][Full Text] [Related]
16. Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.
Russo SB; Tidhar R; Futerman AH; Cowart LA
J Biol Chem; 2013 May; 288(19):13397-409. PubMed ID: 23530041
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary glucocerebrosides from sea cucumber on the brain sphingolipid profiles of mouse models of Alzheimer's disease.
Song Y; Cong P; Lu L; Wang Y; Tang Q; Zhang H; Xu J; Xue C
Food Funct; 2017 Mar; 8(3):1271-1281. PubMed ID: 28232989
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection.
Li JF; Qu F; Zheng SJ; Wu HL; Liu M; Liu S; Ren Y; Ren F; Chen Y; Duan ZP; Zhang JL
Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1725-32. PubMed ID: 24810965
[TBL] [Abstract][Full Text] [Related]
19. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
[TBL] [Abstract][Full Text] [Related]
20. Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China.
Yun H; Sun L; Wu Q; Zong G; Qi Q; Li H; Zheng H; Zeng R; Liang L; Lin X
PLoS Med; 2020 Dec; 17(12):e1003451. PubMed ID: 33296380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
